The University of Oxford and AstraZeneca plan to start testing their COVID-19 vaccination in 5- to 12-year-olds as schools and nurseries reopen in the UK, Bloomberg reported on Sundat.
While children were excluded from the university's early research efforts, when the vaccine moves into the more advanced stages of research in June, it will be administered to as many as 10,260 people, some of them children.
A spokesman for the Oxford COVID-19 vaccine team said further information on the child portion of the study will be available when the group starts recruiting patients in the coming weeks.
One incentive of taking part in the study will be that the researchers will give the child their other routine immunisations on home visits for the length of the trial, but there is no financial gain for the parents, who can withdraw their child at any point.
To read more NewsPoints articles, click here.